• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Molina Healthcare Inc

    2/14/25 9:44:09 AM ET
    $MOH
    Medical Specialities
    Health Care
    Get the next $MOH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 2)


    MOLINA HEALTHCARE INC

    (Name of Issuer)


    COMMON STOCK

    (Title of Class of Securities)


    60855R100

    (CUSIP Number)


    12/31/2024

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    60855R100


    1Names of Reporting Persons

    T. Rowe Price Associates, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MARYLAND
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,542,842.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    2,620,701.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,621,607.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    4.6 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    MOLINA HEALTHCARE INC
    (b)Address of issuer's principal executive offices:

    200 OCEANGATE, SUITE 100, LONG BEACH, CA, 90802
    Item 2. 
    (a)Name of person filing:

    T. Rowe Price Associates, Inc.
    (b)Address or principal business office or, if none, residence:

    100 E. Pratt Street, Baltimore, MD 21202
    (c)Citizenship:

    Maryland
    (d)Title of class of securities:

    COMMON STOCK
    (e)CUSIP No.:

    60855R100
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    2621607
    (b)Percent of class:

    4.6  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    2542842

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    2620701

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    T. Rowe Price Associates, Inc.
     
    Signature:Ellen York
    Name/Title:Vice President
    Date:02/14/2025
    Get the next $MOH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MOH

    DatePrice TargetRatingAnalyst
    4/22/2025$414.00Outperform
    Bernstein
    4/15/2025$375.00Outperform → Neutral
    Robert W. Baird
    3/5/2025$295.00 → $372.00Equal Weight → Overweight
    Wells Fargo
    12/17/2024$378.00 → $350.00Neutral
    Analyst
    5/30/2024$405.00Outperform
    Robert W. Baird
    3/28/2024$439.00Neutral → Underperform
    BofA Securities
    3/6/2024$437.00Equal Weight
    Barclays
    2/15/2024$367.00 → $420.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $MOH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bernstein initiated coverage on Molina Healthcare with a new price target

      Bernstein initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $414.00

      4/22/25 7:34:03 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Molina Healthcare from Outperform to Neutral and set a new price target of $375.00

      4/15/25 9:27:54 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Molina Healthcare from Equal Weight to Overweight and set a new price target of $372.00 from $295.00 previously

      3/5/25 7:37:05 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/14/24 1:22:34 PM ET
      $MOH
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Molina Healthcare Inc

      SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/12/24 12:53:29 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/8/24 10:34:33 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Molina Healthcare Inc

      SCHEDULE 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      5/14/25 10:45:26 AM ET
      $MOH
      Medical Specialities
      Health Care
    • SEC Form S-8 filed by Molina Healthcare Inc

      S-8 - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      5/1/25 4:26:20 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      5/1/25 4:17:16 PM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molina Healthcare Reports First Quarter 2025 Financial Results

      Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below:   Three months ended   March 31,   2025   2024         (In millions, except per-share results) Premium Revenue $10,628   $9,504 Total Revenue $11,147   $9,931         GAAP:       Net Income $298   $301 EPS – Diluted $5.45   $5.17 Medical Care Ratio (MCR) 89.2%   88.5% G&A Ratio 6.9%   7.2

      4/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Wins Illinois Contract to Provide a Dual Eligible Special Needs Plan

      Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that the Company's subsidiary, Molina Healthcare of Illinois, Inc., was one of four managed care organizations awarded a contract by the Illinois Department of Healthcare and Family Services to provide a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). This contract will replace the State's Medicare-Medicaid Alignment Initiative (MMAI) demonstration program, which currently serves approximately 73,000 beneficiaries. The go-live date for the new contract is expected to be January 1, 2026. The contract is expected to have an initial term of four years, with the option to extend the contract from the init

      3/18/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces First Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations

      3/5/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Financials

    Live finance-specific insights

    See more
    • Molina Healthcare Reports First Quarter 2025 Financial Results

      Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below:   Three months ended   March 31,   2025   2024         (In millions, except per-share results) Premium Revenue $10,628   $9,504 Total Revenue $11,147   $9,931         GAAP:       Net Income $298   $301 EPS – Diluted $5.45   $5.17 Medical Care Ratio (MCR) 89.2%   88.5% G&A Ratio 6.9%   7.2

      4/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces First Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations

      3/5/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Reports Fourth Quarter and Year-End 2024 Financial Results

      Introduces Full Year 2025 Revenue and Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. The Company also reported full year 2024 GAAP earnings per diluted share of $20.42 and adjusted earnings per diluted share of $22.65. Financial results are summarized below:   Three months ended   Year ended   December 31,   December 31,   2024   2023   2024   2023                 (In millions, except per-s

      2/5/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Orlando Steven J sold $318,580 worth of shares (1,000 units at $318.58) (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      5/5/25 4:36:49 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Grohowski Leo P was granted 118 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      5/2/25 4:43:52 PM ET
      $MOH
      Medical Specialities
      Health Care
    • New insider Grohowski Leo P claimed no ownership of stock in the company (SEC Form 3)

      3 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      5/2/25 4:40:53 PM ET
      $MOH
      Medical Specialities
      Health Care